Annual Retained Earnings
$9.19 B
-$2.37 B-20.53%
March 31, 2024
Summary
- As of March 8, 2025, TAK annual retained earnings is $9.19 billion, with the most recent change of -$2.37 billion (-20.53%) on March 31, 2024.
- During the last 3 years, TAK annual retained earnings has fallen by -$4.50 billion (-32.85%).
- TAK annual retained earnings is now -66.34% below its all-time high of $27.31 billion, reached on March 31, 2011.
Performance
TAK Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
$8.22 B
-$1.80 B-17.99%
December 1, 2024
Summary
- As of March 8, 2025, TAK quarterly retained earnings is $8.22 billion, with the most recent change of -$1.80 billion (-17.99%) on December 1, 2024.
- Over the past year, TAK quarterly retained earnings has stayed the same.
- TAK quarterly retained earnings is now -73.00% below its all-time high of $30.45 billion, reached on September 30, 2011.
Performance
TAK Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
TAK Retained Earnings Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -20.5% | 0.0% |
3 y3 years | -32.9% | -28.9% |
5 y5 years | -36.1% | -39.9% |
TAK Retained Earnings Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -32.9% | at low | -35.5% | at low |
5 y | 5-year | -36.1% | at low | -40.7% | at low |
alltime | all time | -66.3% | +17.2% | -73.0% | at low |
Takeda Pharmaceutical Company Limited Retained Earnings History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | - | $8.22 B(-18.0%) |
Sep 2024 | - | $10.02 B(+20.6%) |
Jun 2024 | - | $8.32 B(-9.5%) |
Mar 2024 | $9.19 B(-20.5%) | $9.19 B(-7.2%) |
Dec 2023 | - | $9.90 B(+2.3%) |
Sep 2023 | - | $9.68 B(-5.9%) |
Jun 2023 | - | $10.29 B(-11.0%) |
Mar 2023 | $11.57 B(-4.6%) | $11.57 B(+0.6%) |
Dec 2022 | - | $11.50 B(+8.6%) |
Sep 2022 | - | $10.59 B(-0.9%) |
Jun 2022 | - | $10.69 B(-11.8%) |
Mar 2022 | $12.12 B(-11.4%) | $12.12 B(-4.9%) |
Dec 2021 | - | $12.75 B(-8.0%) |
Sep 2021 | - | $13.86 B(+1.9%) |
Jun 2021 | - | $13.60 B(-0.6%) |
Mar 2021 | $13.69 B(+8.0%) | $13.69 B(+8.0%) |
Dec 2020 | - | $12.67 B(+0.1%) |
Sep 2020 | - | $12.65 B(+2.4%) |
Jun 2020 | - | $12.36 B(-2.5%) |
Mar 2020 | $12.68 B(-11.9%) | $12.68 B(+0.1%) |
Dec 2019 | - | $12.66 B(-7.5%) |
Sep 2019 | - | $13.69 B(+5.1%) |
Jun 2019 | - | $13.02 B(-9.5%) |
Mar 2019 | $14.39 B(-1.8%) | $14.39 B(-1.7%) |
Dec 2018 | - | $14.63 B(+0.9%) |
Sep 2018 | - | $14.50 B(+0.6%) |
Jun 2018 | - | $14.42 B(-1.6%) |
Mar 2018 | $14.65 B(+8.4%) | $14.65 B(+2.6%) |
Dec 2017 | - | $14.28 B(-0.5%) |
Sep 2017 | - | $14.35 B(+1.3%) |
Jun 2017 | - | $14.16 B(+4.7%) |
Mar 2017 | $13.52 B(-0.2%) | $13.52 B(+1.7%) |
Dec 2016 | - | $13.30 B(-14.4%) |
Sep 2016 | - | $15.55 B(+3.1%) |
Jun 2016 | - | $15.08 B(+11.3%) |
Mar 2016 | $13.55 B | $13.55 B(+3.2%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2015 | - | $13.13 B(-1.2%) |
Sep 2015 | - | $13.29 B(+4.4%) |
Jun 2015 | - | $12.73 B(-4.6%) |
Mar 2015 | $13.34 B(-27.8%) | $13.34 B(-12.7%) |
Dec 2014 | - | $15.28 B(-11.1%) |
Sep 2014 | - | $17.18 B(-6.0%) |
Jun 2014 | - | $18.27 B(-1.1%) |
Mar 2014 | $18.48 B(-9.8%) | $18.48 B(-12.4%) |
Dec 2013 | - | $21.08 B(-7.8%) |
Sep 2013 | - | $22.86 B(+2.3%) |
Jun 2013 | - | $22.35 B(+9.2%) |
Mar 2013 | $20.47 B(-12.3%) | $20.47 B(-21.8%) |
Dec 2012 | - | $26.18 B(-11.7%) |
Sep 2012 | - | $29.66 B(+3.7%) |
Jun 2012 | - | $28.61 B(+22.6%) |
Mar 2012 | $23.33 B(-14.6%) | $23.33 B(-20.8%) |
Dec 2011 | - | $29.48 B(-3.2%) |
Sep 2011 | - | $30.45 B(+7.9%) |
Jun 2011 | - | $28.21 B(+3.3%) |
Mar 2011 | $27.31 B(+17.9%) | $27.31 B(-0.6%) |
Dec 2010 | - | $27.48 B(+2.9%) |
Sep 2010 | - | $26.72 B(+9.5%) |
Jun 2010 | - | $24.40 B(+5.4%) |
Mar 2010 | $23.16 B(+13.9%) | $23.16 B(+1.2%) |
Dec 2009 | - | $22.87 B(-3.4%) |
Sep 2009 | - | $23.68 B(+16.5%) |
Mar 2009 | $20.32 B(-19.5%) | $20.32 B(-10.9%) |
Dec 2008 | - | $22.80 B |
Mar 2008 | $25.26 B(+29.7%) | - |
Mar 2007 | $19.48 B(+11.3%) | - |
Mar 2006 | $17.51 B(+2.3%) | - |
Mar 2005 | $17.12 B(+10.4%) | - |
Mar 2004 | $15.51 B(+31.5%) | - |
Mar 2003 | $11.80 B(+33.4%) | - |
Mar 2002 | $8.85 B(+12.8%) | - |
Mar 2001 | $7.84 B | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual retained earnings?
- What is the all time high annual retained earnings for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual retained earnings year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly retained earnings?
- What is the all time high quarterly retained earnings for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly retained earnings year-on-year change?
What is Takeda Pharmaceutical Company Limited annual retained earnings?
The current annual retained earnings of TAK is $9.19 B
What is the all time high annual retained earnings for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual retained earnings is $27.31 B
What is Takeda Pharmaceutical Company Limited annual retained earnings year-on-year change?
Over the past year, TAK annual retained earnings has changed by -$2.37 B (-20.53%)
What is Takeda Pharmaceutical Company Limited quarterly retained earnings?
The current quarterly retained earnings of TAK is $8.22 B
What is the all time high quarterly retained earnings for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly retained earnings is $30.45 B
What is Takeda Pharmaceutical Company Limited quarterly retained earnings year-on-year change?
Over the past year, TAK quarterly retained earnings has changed by $0.00 (0.00%)